Overview
Opioid dependence involves compulsive opioid use despite harmful consequences, often requiring agonist therapy like methadone or buprenorphine to manage withdrawal symptoms and reduce illicit opioid use 1.Diagnosis
Clinical history of opioid use and functional impairment
Physical examination for signs of opioid use disorder
Laboratory tests: urine toxicology screening for opioids 1Management
First-line treatments:
- Methadone maintenance therapy (doses individualized, typically 30-120 mg/day) 1
- Buprenorphine/naloxone (Suboxone) (doses typically 12-24 mg/day) 1
Adjunctive treatments:
- Cognitive-behavioral therapy (CBT) 1
- Contingency management interventions 1Special Populations
No specific data provided in the abstracts for pregnancy, pediatrics, elderly, or comorbidities 1.Key Recommendations
Utilize methadone or buprenorphine/naloxone for agonist maintenance therapy to stabilize patients with opioid dependence (Evidence: Strong) 1
Individualize dosing based on patient response and clinical outcomes (Evidence: Moderate) 1
Incorporate psychosocial interventions such as CBT to enhance treatment outcomes (Evidence: Moderate) 1References
1 Panni MK, Fernandes M, Mohdazhar N, Taylor T, Tomasi A, Corn SB. A novel ambulatory intravenous holder: preliminary findings. Anesthesia and analgesia 2002. link